Partillion Bioscience is an early stage life science company aiming to democratize advanced single-cell assays with its award-winning nanovial platform. Our novel platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological function such as secreted proteins. The validated technology underpinning Partillion’s products has been featured in notable journals such as Science Advances, Advanced Functional Materials, and Lab on Chip and received industry accolades, winning the 2020 SLAS Innovation Award.
Location: United States, California, Los Angeles
Employees: 11-50
Total raised: $9.87M
Founded date: 2020
Investors 2
| Date | Name | Website |
| 03.11.2025 | ND CAPITAL | nd.capital |
| - | Paladin Ca... | paladincap... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.10.2023 | Seed | $5M | - |
| 30.12.2022 | - | $4.87M | - |
Mentions in press and media 3
| Date | Title | Description |
| 09.10.2023 | Partillion Bioscience: $5 Million In Seed Funding Closed | Partillion Bioscience Corporation – a life science tools company – recently announced the closing of a $5 million seed financing round, expansion of its board of directors, and a multiyear agreement with Alloy Therapeutics as a Preferred Pa... |
| 27.09.2023 | Partillion Bioscience Raises $5M in Seed Financing | Partillion Bioscience Corporation, a Los Angeles, CA-based life science tools company, raised $5M in Seed funding. Backers included ND Capital, Vertical Venture Partners, and Paladin Capital. Eric Moessinger, Partner at ND Capital, Paul Con... |
| - | Partillion Bioscience | “Unlock your research today with the word's first functional single-cell biology reagent platform. Next generation assay kits for single-cell secretion analysis and more.” |